Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2024 Filed Feb 12, 2024 23:16 UTC |
Fischer David BDirector
|
GrantStock Option · Derivative | 1,730 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007102 · form4.xml · derivative · entry 2 Fischer David B · CIK 0001305182 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730 Underlying: Common Stock · 1,730 shares Expires 2034-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:16 UTC |
Fischer David BDirector
|
GrantCommon Stock | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007102 · form4.xml · nonDerivative · entry 1 Fischer David B · CIK 0001305182 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,009 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:12 UTC |
Backus William A.VP & Chief Accounting Officer
|
GrantStock Option · Derivative | 1,900 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007100 · form4.xml · derivative · entry 4 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,900 Underlying: Common Stock · 1,900 shares Expires 2034-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:12 UTC |
Backus William A.VP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,130 | $143.43 | $162,075.90 |
DisclosureSEC source: 0001140361-24-007100 · form4.xml · nonDerivative · entry 3 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,665 F4 · shares: 1,130 of the 2,119 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:12 UTC |
Backus William A.VP & Chief Accounting Officer
|
GrantCommon Stock | 2,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007100 · form4.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,795 F3 · shares: Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:12 UTC |
Backus William A.VP & Chief Accounting Officer
|
GrantCommon Stock | 570 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007100 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,676 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:07 UTC |
Wineinger Matthew DavidDirector
|
GrantStock Option · Derivative | 1,730 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007093 · form4.xml · derivative · entry 2 Wineinger Matthew David · CIK 0001652942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730 Underlying: Common Stock · 1,730 shares Expires 2034-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:07 UTC |
Wineinger Matthew DavidDirector
|
GrantCommon Stock | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007093 · form4.xml · nonDerivative · entry 1 Wineinger Matthew David · CIK 0001652942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,495 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| September 11, 2023 Filed Sep 12, 2023 20:15 UTC |
Fischer David BDirector
|
SaleCommon Stock | 3,800 | $131.57 | $499,978.54 |
DisclosureSEC source: 0001140361-23-043667 · form4.xml · nonDerivative · entry 1 Fischer David B · CIK 0001305182 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,469 F1 · shares: This transaction was executed in multiples sales ranging from $131.3100 to $131.6850 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 20:16 UTC |
Miyata HatsukiEVP, Gen. Counsel & Secretary
|
Tax withholdingCommon Stock | 482 | $128.54 | $61,956.28 |
DisclosureSEC source: 0001140361-23-037034 · form4.xml · nonDerivative · entry 1 Miyata Hatsuki · CIK 0001939613 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,489 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 7/27/2022). F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| May 02, 2023 Filed May 4, 2023 20:15 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
SaleCommon Stock | 2,300 | $130.36 | $299,836.74 |
DisclosureSEC source: 0001140361-23-022963 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,424 F1 · shares: This transaction was executed in multiples sales ranging from $129.9700 to $130.9000 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| March 20, 2023 Filed Mar 22, 2023 20:15 UTC |
Fischer David BDirector
|
SaleCommon Stock | 3,000 | $127.01 | $381,021.00 |
DisclosureSEC source: 0001140361-23-013065 · form4.xml · nonDerivative · entry 1 Fischer David B · CIK 0001305182 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,269 F1 · shares: This transaction was executed in multiples sales ranging from $127.000 to $127.100 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:16 UTC |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
Tax withholdingCommon Stock | 264 | $135.67 | $35,816.88 |
DisclosureSEC source: 0001140361-23-007252 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,604 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:16 UTC |
Tignor Michael BrentSVP & Chief HR Officer
|
Tax withholdingCommon Stock | 297 | $135.67 | $40,293.99 |
DisclosureSEC source: 0001140361-23-007250 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,879 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:15 UTC |
Bengtsson Carl MartinEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 501 | $135.67 | $67,970.67 |
DisclosureSEC source: 0001140361-23-007251 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,242 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:15 UTC |
TELEVANTOS JOHN YDirector
|
Tax withholdingCommon Stock | 258 | $135.67 | $35,002.86 |
DisclosureSEC source: 0001140361-23-007249 · form4.xml · nonDerivative · entry 1 TELEVANTOS JOHN Y · CIK 0001236561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,078 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:15 UTC |
Harris Theodore LDirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 2,568 | $135.67 | $348,400.56 |
DisclosureSEC source: 0001140361-23-007246 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,897 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:15 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
Tax withholdingCommon Stock | 278 | $135.67 | $37,716.26 |
DisclosureSEC source: 0001140361-23-007248 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,618 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:15 UTC |
Backus William A.VP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 332 | $135.67 | $45,042.44 |
DisclosureSEC source: 0001140361-23-007247 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,964 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:15 UTC |
Griffin Jonathan HarrisonSVP & GM, Animal Nutrition
|
Tax withholdingCommon Stock | 207 | $135.67 | $28,083.69 |
DisclosureSEC source: 0001140361-23-007245 · form4.xml · nonDerivative · entry 1 Griffin Jonathan Harrison · CIK 0001907718 · SVP & GM, Animal Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,515 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Tignor Michael BrentSVP & Chief HR Officer
|
GrantStock Option · Derivative | 2,300 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006116 · form4.xml · derivative · entry 4 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 Underlying: Common Stock · 2,300 shares Expires 2033-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Tignor Michael BrentSVP & Chief HR Officer
|
Tax withholdingCommon Stock | 1,060 | $138.09 | $146,375.40 |
DisclosureSEC source: 0001140361-23-006116 · form4.xml · nonDerivative · entry 3 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,176 F4 · shares: 1,060 of the 1,989 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Tignor Michael BrentSVP & Chief HR Officer
|
GrantCommon Stock | 1,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006116 · form4.xml · nonDerivative · entry 2 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,236 F3 · shares: Represents the vesting of performance stock units (includes 30 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Tignor Michael BrentSVP & Chief HR Officer
|
GrantCommon Stock | 660 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006116 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,247 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
GrantStock Option · Derivative | 1,600 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006117 · form4.xml · derivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires 2033-02-08 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
Tax withholdingCommon Stock | 918 | $138.09 | $126,766.62 |
DisclosureSEC source: 0001140361-23-006117 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,868 F3 · shares: 918 of the 1,636 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
GrantCommon Stock | 1,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006117 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,786 F2 · shares: Represents the vesting of performance stock units (includes 24 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
GrantCommon Stock | 460 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006117 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,150 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
GrantStock Option · Derivative | 2,000 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006115 · form4.xml · derivative · entry 4 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2033-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
Tax withholdingCommon Stock | 999 | $138.09 | $137,951.91 |
DisclosureSEC source: 0001140361-23-006115 · form4.xml · nonDerivative · entry 3 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,896 F4 · shares: 999 of the 2,163 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
GrantCommon Stock | 2,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006115 · form4.xml · nonDerivative · entry 2 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,895 F3 · shares: Represents the vesting of performance stock units (includes 31 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
GrantCommon Stock | 580 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006115 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,732 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Harris Theodore LDirector · Chairman, President & CEO
|
GrantStock Option · Derivative | 21,200 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006114 · form4.xml · derivative · entry 4 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,200 Underlying: Common Stock · 21,200 shares Expires 2033-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Harris Theodore LDirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 8,864 | $138.09 | $1,224,029.76 |
DisclosureSEC source: 0001140361-23-006114 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,465 F4 · shares: 8,864 of the 17,344 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Harris Theodore LDirector · Chairman, President & CEO
|
GrantCommon Stock | 17,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006114 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,329 F3 · shares: Represents the vesting of performance stock units (includes 256 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC |
Harris Theodore LDirector · Chairman, President & CEO
|
GrantCommon Stock | 6,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006114 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,985 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Backus William A.VP & Chief Accounting Officer
|
GrantStock Option · Derivative | 2,000 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006113 · form4.xml · derivative · entry 4 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2033-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Backus William A.VP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,190 | $138.09 | $164,327.10 |
DisclosureSEC source: 0001140361-23-006113 · form4.xml · nonDerivative · entry 3 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,296 F4 · shares: 1,190 of the 2,240 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Backus William A.VP & Chief Accounting Officer
|
GrantCommon Stock | 2,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006113 · form4.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,486 F3 · shares: Represents the vesting of performance stock units (includes 32 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Backus William A.VP & Chief Accounting Officer
|
GrantCommon Stock | 570 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006113 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,246 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Bengtsson Carl MartinEVP & Chief Financial Officer
|
GrantStock Option · Derivative | 5,500 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006112 · form4.xml · derivative · entry 4 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2033-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Bengtsson Carl MartinEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 1,759 | $138.09 | $242,900.31 |
DisclosureSEC source: 0001140361-23-006112 · form4.xml · nonDerivative · entry 3 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,743 F4 · shares: 1,759 of the 3,372 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Bengtsson Carl MartinEVP & Chief Financial Officer
|
GrantCommon Stock | 3,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006112 · form4.xml · nonDerivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,502 F3 · shares: Represents the vesting of performance stock units (includes 50 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Bengtsson Carl MartinEVP & Chief Financial Officer
|
GrantCommon Stock | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006112 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,130 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Griffin Jonathan HarrisonSVP & GM, Animal Nutrition
|
GrantStock Option · Derivative | 2,500 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006111 · form4.xml · derivative · entry 4 Griffin Jonathan Harrison · CIK 0001907718 · SVP & GM, Animal Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2033-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Griffin Jonathan HarrisonSVP & GM, Animal Nutrition
|
Tax withholdingCommon Stock | 758 | $138.09 | $104,672.22 |
DisclosureSEC source: 0001140361-23-006111 · form4.xml · nonDerivative · entry 3 Griffin Jonathan Harrison · CIK 0001907718 · SVP & GM, Animal Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,722 F4 · shares: 758 of the 2,279 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Griffin Jonathan HarrisonSVP & GM, Animal Nutrition
|
GrantCommon Stock | 2,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006111 · form4.xml · nonDerivative · entry 2 Griffin Jonathan Harrison · CIK 0001907718 · SVP & GM, Animal Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,480 F3 · shares: Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC |
Griffin Jonathan HarrisonSVP & GM, Animal Nutrition
|
GrantCommon Stock | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006111 · form4.xml · nonDerivative · entry 1 Griffin Jonathan Harrison · CIK 0001907718 · SVP & GM, Animal Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,201 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:12 UTC |
Reid Martin LutherSVP Chief Supply Chain Officer
|
GrantStock Option · Derivative | 2,800 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006046 · form4.xml · derivative · entry 2 Reid Martin Luther · CIK 0001906692 · SVP Chief Supply Chain Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 Underlying: Common Stock · 2,800 shares Expires 2033-02-08 F3 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:12 UTC |
Reid Martin LutherSVP Chief Supply Chain Officer
|
GrantCommon Stock | 810 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006046 · form4.xml · nonDerivative · entry 1 Reid Martin Luther · CIK 0001906692 · SVP Chief Supply Chain Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,259 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.